UnknownNot Applicable

Fertility and Cardiovascular Risk in Men With Metabolic Syndrome

Germany70 participantsStarted 2021-01-01

Plain-language summary

Men diagnosed with metabolic syndrome (MetS) including obesity, hypertension, dyslipidemia and infertility will be assessed for cardiovascular and diabetes risk. The eligible patient will be randomised to one-year life-style intervention program including nutritional, behavioural and exercise counselling or standard care by the general physician. The aim of the program is to reduce cardiovascular and diabetes risks and hypogonadism as well.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age\>18 years, wish for fatherhood in stable partnership, metabolic syndrome according to guidelines (minimum 3 out of 5 criteria), ready to participate in 1-yr lifestyle program Exclusion Criteria: * Not conforming to MetS diagnosis criteria, sterilisation, promiscuous behaviour, contraindications against established medical or surgical treatment of obesity, participation in another weight-loss program

What they're measuring

Number of participants with normalisation of diabetes or cardiovascular risk or improvement of hypogonadism

Timeframe: 1 year

Trial details

NCT IDNCT03977064

SponsorUniversity of Giessen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

Contact for this trial

Thomas Linn, MD

+49 641 985 57017 thomas.linn@innere.med.uni-giessen.de

View on ClinicalTrials.gov More Metabolic Syndrome trials